PMDA drug package insert
アズレン含嗽液アーズミンうがい液1％
PMDA Prescription drug · 本草製薬株式会社 · package insert Mar 27, 2024
Key facts
| Brand names | アズレン含嗽液アーズミンうがい液1％ |
|---|---|
| Nonproprietary names | アズレンスルホン酸ナトリウム水和物 |
| Companies | 製造販売元／本草製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | アズレン含嗽液 |
| Therapeutic category codes | 87226 |
| YJ codes | 2260700F2036 |
| Approval numbers | 21700AMZ00033000 |
| Package insert edition | 第2版 |
| Package insert date | Mar 27, 2024 |
| PMDA document key | 710082_2260700F2036_1 |
| PMDA company code | 710082 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: